SESSION TITLE: Medical Student/Resident Lung Cancer Posters SESSION TYPE: Med Student/Res Case Rep Postr PRESENTED ON: October 18-21, 2020 INTRODUCTION: Carcinoma of the lung is an uncommon condition during pregnancy. We present here a case of a young 32-year-old female G4P3003 with a 2 pack-year history of smoking who presented to the hospital for a spontaneous vaginal delivery and was found to have a new squamous cell carcinoma of the lung metastatic to the placenta. CASE PRESENTATION: 32 year-old-female G4P3003 with a 2 pack-year history of smoking presented to the hospital at 39w2d for the management of labor. The pregnancy course was complicated by unintentional weight loss of 10 pounds in the last 3 months. She was admitted to the labor and delivery unit and underwent spontaneous vaginal delivery of a healthy baby boy and the placenta was sent to the pathology department for evaluation. 24 hours after the delivery the patient developed dyspnea and required 2L of oxygen to maintain SpO2 >92%. She has had no night sweats, fevers, chills, nor any productive cough including hemoptysis. On auscultation, there was diffuse wheezing throughout the lung fields bilaterally. The patient was placed on a bronchodilator protocol and CTA of the chest was obtained which ruled out a PE but showed a right-sided lung mass with extensive bulky adenopathy involving the right perihilar, paratracheal, subcarinal and pre-carinal regions. She had an EBUS bronchoscopy with TB-FNA of mediastinal mass and right paratracheal and subcarinal lymph nodes. The biopsy showed squamous cell carcinoma of the lung. The tumor cells expressed p40 and cytokeratin 5/6, but negative for p16, TTF-1 and Placental alkaline phosphatase (PLAP). 100% of tumor cells are positive for PD-L1 (membranous positivity). Placenta was analyzed which showed multifocal involvement by squamous cell carcinoma with villous infarcts. Immunohistochemistry markers were similar to the lung biopsy specimen. Additional imaging also showed liver and breast involvement. Thus, the patient was diagnosed with stage IVB (T1c N3 M1c) metastatic SCC and was placed on single-agent pembrolizumab 200 mg IV every 3 weeks. DISCUSSION: Lung cancer metastasizing to the placenta is uncommon. Most of the lung cancers reported in these cases were non-small cell lung cancers. The prognosis in these reported cases was poor and the cancers were inoperable. Very few cases reported harmful consequences for the neonate and there was no direct evidence of adverse effects of pregnancy on the prognosis of lung cancer in pregnant women, but these cases were diagnosed in stages III-IV. Thus, it needs further research on why gestational metastatic cancers follow an aggressive course. Thus, it is important to report similar cases for further research. CONCLUSIONS: Gestational lung cancers diagnosed in advanced stages have aggressive behavior, chemotherapy offers poor results and overall survival is short. Reference #1: Jackisch, C., Louwen, F., Schwenkhagen, A. et al. Arch Gynecol Obstet (2003) 268: 69. https://doi.org/10.1007/s00404-002-0356-x Reference #2: Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126–140. Reference #3: Boussios S., Han S.N., Fuscio R., Halaska M.J., Ottevanger P.B., Peccatori F.A. Lung cancer in pregnancy: report of nine cases from an international collaborative study. Lung Cancer. 2013;82:499–505. DISCLOSURES: No relevant relationships by James Choi, source=Web Response No relevant relationships by Aaron Nichols, source=Web Response No relevant relationships by Fazal Raziq, source=Web Response
Read full abstract